Q3 Earnings Forecast for USPH Issued By Barrington Research

U.S. Physical Therapy, Inc. (NYSE:USPH) – Barrington Research upped their Q3 2025 EPS estimates for U.S. Physical Therapy in a report released on Friday, February 28th. Barrington Research analyst M. Petusky now forecasts that the company will earn $0.67 per share for the quarter, up from their prior forecast of $0.62. Barrington Research currently has a “Outperform” rating and a $98.00 target price on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s Q3 2026 earnings at $0.79 EPS.

USPH has been the subject of a number of other research reports. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. JPMorgan Chase & Co. upped their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 3rd. William Blair restated a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. JMP Securities began coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price for the company. Finally, StockNews.com lowered shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Friday. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $111.50.

U.S. Physical Therapy Price Performance

Shares of NYSE:USPH opened at $79.31 on Monday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The firm has a fifty day moving average price of $88.20 and a 200 day moving average price of $87.65. U.S. Physical Therapy has a fifty-two week low of $76.18 and a fifty-two week high of $113.63. The firm has a market cap of $1.20 billion, a price-to-earnings ratio of 84.37, a P/E/G ratio of 3.54 and a beta of 1.48.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The firm had revenue of $180.45 million during the quarter, compared to analysts’ expectations of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%.

U.S. Physical Therapy Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be given a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.80 annualized dividend and a yield of 2.27%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s dividend payout ratio (DPR) is 95.65%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the transaction, the chief financial officer now owns 20,469 shares in the company, valued at $1,970,141.25. This trade represents a 2.46 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

Several institutional investors have recently made changes to their positions in the company. HighTower Advisors LLC lifted its holdings in shares of U.S. Physical Therapy by 2.5% in the 4th quarter. HighTower Advisors LLC now owns 4,833 shares of the company’s stock worth $429,000 after acquiring an additional 119 shares during the last quarter. CBIZ Investment Advisory Services LLC lifted its holdings in shares of U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after acquiring an additional 122 shares during the last quarter. Albert D Mason Inc. lifted its holdings in shares of U.S. Physical Therapy by 1.3% in the 4th quarter. Albert D Mason Inc. now owns 10,596 shares of the company’s stock worth $940,000 after acquiring an additional 139 shares during the last quarter. Harbor Capital Advisors Inc. lifted its holdings in shares of U.S. Physical Therapy by 1.0% in the 4th quarter. Harbor Capital Advisors Inc. now owns 16,344 shares of the company’s stock worth $1,450,000 after acquiring an additional 156 shares during the last quarter. Finally, Aquatic Capital Management LLC lifted its holdings in shares of U.S. Physical Therapy by 18.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company’s stock worth $115,000 after acquiring an additional 198 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.